Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602712200 on April 28, 2006

J. Biol. Chem., Vol. 281, Issue 29, 20530-20541, July 21, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/29/20530    most recent
M602712200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazel, A.
Right arrow Articles by Blumenberg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazel, A.
Right arrow Articles by Blumenberg, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Inhibition of JNK Promotes Differentiation of Epidermal Keratinocytes*

Alix Gazel{ddagger}, Tomohiro Banno§, Rebecca Walsh{ddagger}, and Miroslav Blumenberg{ddagger}||1

From the Departments of {ddagger}Dermatology, Biochemistry, and ||The Cancer Institute, New York University School of Medicine, New York, New York, 10016 and the §Dermatology Department, Institute of Clinical Medicine, Tsukuba University, 1-1-1 Tennodai, Ibaraki 305-8575, Japan

In inflamed tissue, normal signal transduction pathways are altered by extracellular signals. For example, the JNK pathway is activated in psoriatic skin, which makes it an attractive target for treatment. To define comprehensively the JNK-regulated genes in human epidermal keratinocytes, we compared the transcriptional profiles of control and JNK inhibitor-treated keratinocytes, using DNA microarrays. We identified the differentially expressed genes 1, 4, 24, and 48 h after the treatment with SP600125. Surprisingly, the inhibition of JNK in keratinocyte cultures in vitro induces virtually all aspects of epidermal differentiation in vivo: transcription of cornification markers, inhibition of motility, withdrawal from the cell cycle, stratification, and even production of cornified envelopes. The inhibition of JNK also induces the production of enzymes of lipid and steroid metabolism, proteins of the diacylglycerol and inositol phosphate pathways, mitochondrial proteins, histones, and DNA repair enzymes, which have not been associated with differentiation previously. Simultaneously, basal cell markers, including integrins, hemidesmosome and extracellular matrix components, are suppressed. Promoter analysis of regulated genes finds that the binding sites for the forkhead family of transcription factors are over-represented in the SP600125-induced genes and c-Fos sites in the suppressed genes. The JNK-induced proliferation appears to be secondary to inhibition of differentiation. The results indicate that the inhibition of JNK in epidermal keratinocytes is sufficient to initiate their differentiation program and suggest that augmenting JNK activity could be used to delay cornification and enhance wound healing, whereas attenuating it could be a differentiation therapy-based approach for treating psoriasis.


Received for publication, March 22, 2006 , and in revised form, April 24, 2006.

* This work was supported by a grant from the Dystrophic epidermolysis bullosa Research Association (DebRA) UK Foundation with additional support from DebRA of America. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Dermatology, New York University School of Medicine, 550 First Ave., New York, NY 10016. Tel.: 212-263-5924; Fax: 212-263-8752; E-mail: blumem01{at}med.nyu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
S. Yoshida, N. Kajitani, A. Satsuka, H. Nakamura, and H. Sakai
Ras Modifies Proliferation and Invasiveness of Cells Expressing Human Papillomavirus Oncoproteins
J. Virol., September 1, 2008; 82(17): 8820 - 8827.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Bayo, A. Sanchis, A. Bravo, J. L. Cascallana, K. Buder, J. Tuckermann, G. Schutz, and P. Perez
Glucocorticoid Receptor Is Required for Skin Barrier Competence
Endocrinology, March 1, 2008; 149(3): 1377 - 1388.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. T. Black, J. P. Gray, M. P. Shakarjian, D. L. Laskin, D. E. Heck, and J. D. Laskin
Distinct effects of ultraviolet B light on antioxidant expression in undifferentiated and differentiated mouse keratinocytes
Carcinogenesis, January 1, 2008; 29(1): 219 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement